Active IL-18 requires cleavage of its precursor form by caspase-1; inhibition of caspase-1 also attenuated the depression in contractile force after ischemia (from 35% of control to 75.8% in treated atrial muscle). The gene discussed is CASP1; the disease is ischemia.